Lauren Dembeck, PhD

Researchers sought to determine the efficacy of the COVID-19 vaccine in patients with CLL.

Researcher sought to determine the risk of developing VTE in patients with and without COVID-19 who were hospitalized.

Researchers have identified various factors associated with mortality following a diagnosis with the COVID-19 virus among recipients of allogeneic and autologous HCT.

Findings from a retrospective chart review showed a need to carefully monitor inflammatory biomarkers and anticoagulant dosage in patients with severe COVID-19.

Researchers evaluated coagulation-linked complications in critically ill patients with COVID-19 and survival outcomes following therapeutic anticoagulation.

A multicenter team reported on the administration of COVID-19 convalescent plasma to patients with severe COVID-19 in the Yale-New Haven Health System.

Elective cancer surgery within COVID-19–free surgical pathways results in lower pulmonary complication, SARS-CoV-2 infection, and mortality rates.

Investigators assess underlying mechanisms and relevant biomarkers of morbidity and mortality due to coagulopathy in patients with severe COVID-19 infection.

Risk-adapted therapy effectively prevents fungal infections and reduces neurotoxicity in children with leukemia.

The prevalence of H pylori infection continues to fall in the general population with only 16% of all gastric and 25% of all duodenal patients with ulcer harboring H pylori.